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Abstract 
Objective: To determine the rate of surgical site infections (SSI) in neurosurgical procedures involving a shared-
resource intraoperative magnetic resonance imaging (ioMRI) scanner at a single institution derived from a 
prospective clinical quality management database 
Methods: All consecutive neurosurgical procedures that were performed with a high-field, two-room ioMRI 
between April 2013 and June 2016 were included (N=195; 109 craniotomies and 86 endoscopic transsphenoidal 
procedures). The incidence of surgical site infections (SSI) within three months after surgery was assessed for both 
operative groups (craniotomies versus transsphenoidal approach). 
Results: Of the 109 craniotomies, six patients developed an SSI (5.5%, 95%-Confidence interval [CI]: 1.2%, 9.8%), 
including one superficial SSI, two cases of bone flap osteitis, one intracranial abscess and two cases of 
meningitis/ventriculitis. Wound revision surgery due to infection was necessary in four patients (4%). Of the 86 
transsphenoidal skull base surgeries, six patients (7.0%, 95%-CI: 1.5%, 12.4%) developed an infection, including 
two non-CNS intranasal SSIs (3%) and four cases of meningitis (5%). Logistic regression analysis revealed that the 
likelihood of infection significantly decreased with the number of operations in the new operational setting (odds 
ratio: 0.982, 95%-CI: 0.969-0.995, p=0.008). 
Conclusions: The use of a shared-resource ioMRI in neurosurgery did not demonstrate elevated infection rates as 
compared to the current available literature. The likelihood of infection decreased with the accumulating number of 
operations, underlining the importance of surgical staff training after the introduction of a shared-resource ioMRI. 
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Introduction 
Over the past decade, intraoperative magnetic resonance imaging (ioMRI) has increasingly been implemented for 
numerous neurosurgical procedures.1-7 Although the use of high-field ioMRI has greatly influenced the management 
of neuro-oncological patients by increasing the extent of tumor resection and therefore survival time,8 the acquisition 
and maintenance costs of high-field scanners are considerably high, imposing a challenge for many neurosurgical 
clinics.9 As a cost-effective alternative to the single-room ioMRI, the two-room ioMRI suite comprises a high-field 
scanner that is spatially separated from the operating theater by a double-layered sliding door (Figure 1). This setting 
allows for continuous nonsurgical outpatient MRI examinations outside the intraoperative MRI time window, 
thereby sharing resources and greatly improving the scanner’s cost-effectiveness.10 
While procedures in one-room intraoperative MRI suites have infection rates as low as conventional operations,11,12 
there are concerns whether such a shared-resource design imposes a greater risk for infections or anesthesia related 
complications.13 For example, patient transportation into the MRI room imposes a challenge to anesthesia and it is 
still unclear whether exposure to a non-sterile environment such as the ioMRI, the repetitive draping and undraping 
of the operation site as well as the longer procedure time of approximately one hour increase the risk of surgical site 
infections.13 While several studies find low infection rates in shared-resource designs,9,14-16 their validity is restricted 
as they only investigated a small number of patients and rarely included transsphenoidal procedures.  
This study is part of an ongoing quality assessment of neurosurgical complication rates at our clinic.17 Specifically, 
in this study we prospectively documented surgical site infections (SSIs) after 195 consecutive procedures involving 
a two-room ioMRI. The rates of infections and infection-related reoperations of two operative groups (craniotomies 
and transsphenoidal approaches) were then compared to rates from previous studies without ioMRIs and single-room 
scanners to assess whether the use of this two-room setting imposes a greater infection risk for patients. Furthermore, 
logistic regression analysis was used to determine whether the likelihood of infection changes with the accumulative 
number of operations performed in this new setting. 
 
 
Dinevski 4 
 
Material and methods  
Patients 
We prospectively documented all 195 consecutive neurosurgical interventions with our two-room ioMRI that 
occurred between April 2013 and June 2016. Ethical board approval was given (KEK-ZH 2012-0244). Operations 
were performed by eleven surgeons at the University Hospital Zurich, led by one of the two senior authors. The use 
of the ioMRI was decided upon medical indication and the surgeon’s preference. The surgeries were grouped by 
approach (109 craniotomies on 102 patients and 86 transsphenoidal skull base surgeries on 79 patients). This 
grouping accounts for the surgical site’s difference in level of contamination: All craniotomies were clean 
operations, all transsphenoidal surgeries were clean-contaminated entries.18,19 In addition to the 195 cases, one spinal 
case was performed with the ioMRI. This case was not followed by an infection, but it was not included into the 
study because the entry and operative protocol considerably differs from the cranial surgeries. All operations were 
elective procedures and all patients preoperatively consented to clinical data analysis. Patient characteristics are 
listed in Table 1. 
Two-room ioMRI unit 
The two-room ioMRI unit at our facility contains a 3T MRI (MAGNETOM® Skyra, Siemens Healthcare, Erlangen, 
Germany), which is located adjacent to the operating room and separated from it through a sliding double-door 
(Figure 1A). The scanner room is accessible from outside the operating floor, allowing for outpatient scans outside 
the intraoperative MRI time window. On average, 15 outpatient MRI scans are performed on the scanner when an 
ioMRI case is planned for that day. The MRI room is radiofrequency shielded, whereas the operating room does not 
have further modifications apart from the sliding doors. Aside from MRI-compatible anesthesia equipment and the 
non-ferromagnetic head holder and coils (Noras MRI products, Germany), standard ferromagnetic operating 
equipment was used. 
Anesthesia 
All procedures were performed under general anesthesia, which was induced via intravenous application of Fentanyl 
(2-3 µg/kg) and Propofol (1.5-2 mg/kg) with facilitation of intratracheal intubation by Atracurium (0.5 mg/kg). 
Anesthesia was maintained with Remifentanil (0.1-2 µg/kg/min) and Propofol (5-10 mg/kg/h), while relaxation was 
continued with Atracurium (0.5 mg/kg/h) unless intraoperative neurophysiological monitoring (IONM) was 
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performed. Equipment that remained on the patient during ioMRI was MR-compatible. In contrast to surgeries 
without ioMRI, no electrodes were applied to record the bispectral index (BIS). 
Surgical procedure and ioMRI protocol 
Preoperatively, all patents were given one dose of Cefuroxime as antibiotic prophylaxis (1500mg for adults, weight-
adjusted for pediatric patients) and a second dose if the surgery exceeded 4 hours. Vancomycin or Clindamycin 
(second-line) was selected if allergies to Cefuroxime were known. Craniotomy patients were not shaved but the hair 
was occasionally shortened with an electric razor. After fixation in the MRI-compatible headrest, craniotomy 
patients were draped and the operative site disinfected with chlorhexidine solution. In transsphenoidal surgery, the 
facial skin was disinfected with povidone-iodine solution from both eyebrows to the upper lip. While the nasal 
vestibule skin was disinfected with the same agent, the depth of the nasal cavity was not disinfected. Special care 
was taken to prevent MR image distortions and tissue heating in surgeries with IONM.20 Instruments like 
neuronavigation (Stealthstation® S7, Medtronic, United States), microscope (Pentero® 900, Zeiss, Germany), 
intraoperative sonography (iU 22, Philips, Netherlands) and endoscope (Storz, Germany) were routinely used as in 
surgeries without ioMRI. 
The surgeon decided when to use the intraoperative MRI and reserved the scanner room one hour prior to its use. 15 
minutes before the scan, the MRI-room was cleaned and locked against the outpatient area (Figure 1A). Before 
opening the door to the scanner, the surgical site was provisionally closed and covered with sterile incise drapes 
(OPSITETM, Smith & Nephew, United Kingdom). Neuronavigation and dispensable operating equipment was 
removed. The patient was then fully covered with three sterile layers. After going through checklists with standard 
operating procedures, the sliding doors were opened and the patient was transferred to the ioMRI in the adjacent 
room (Figure 1B). During scanning the doors to the OR were kept closed. After ioMRI, the patient was transferred 
back to the operating room and re-draped to continue surgery. The intraoperative scan and the additional measures 
associated with it prolonged surgery time by approximately one hour. Upon surgeon’s decision, subgaleal drains 
were postoperatively placed for 48 hours. If necessary, lumbar drains were placed for a varying length of time. 
 
Assessment of postoperative complications and data collection 
Patients’ postoperative course was assessed daily until discharge and three months after surgery. Wound 
complications were assessed by the attending neurosurgeon on the ward and revision surgery was performed if 
necessary. SSIs were categorized according to the Centers for Disease Control and Prevention (CDC, Atlanta, GA 
Dinevski 6 
USA) guidelines with modifications for neurosurgical procedures.19, 21 Although the CDC guidelines define that an 
SSI must occur within 30 days after surgery (or one year if a device is implanted), we considered a follow-up period 
of 90 days as more appropriate to detect surgically related infections. 
Postoperative infections after craniotomy were defined as follows: Superficial incisional SSIs were considered if the 
infection involved the skin or subcutaneous tissue and diagnosed in the presence of purulent discharge, isolated 
organisms from serous drainage or by clinical diagnosis of the attending physician. Deep incisional/organ-space SSIs 
were considered when an infection involved deeper tissues and include bone flap osteitis (diagnosed 
surgically/clinically or by cranial imaging), meningitis-ventriculitis, intracranial abscesses or empyema (diagnosed 
surgically/clinically, by microbial testing or by cranial imaging). 
Since the CDC definitions of surgical site infections are not directly applicable to intranasal incisions, postoperative 
infections after transsphenoidal surgery were defined as follows: Intranasal SSIs included postoperative infections of 
the nasal and paranasal cavities with positive culture samples without infection of the CNS. Deep incisional/organ-
space SSIs described all infections of the CNS and included infections of the dural closure or graft, meningitis-
ventriculitis and intracranial abscesses or empyema. Meningitis-ventriculitis was also defined according to the CDC 
guidelines and diagnosed when patients had organisms cultured from the CSF or when they showed clinical signs of 
meningitis (fever >38°C, headache, stiff neck, meningeal signs, cranial nerve signs, irritability) and had lab results 
suggestive of meningitis (increased white cells, elevated protein, decreased glucose in CSF, detectable organisms on 
Gram’s stain of CSF, positive blood cultures, positive antigen test or antibody titer).21 
Swabs of the wound, blood cultures or CSF samples were sent for microbiological testing if a patient showed signs 
of an infection (erythema, wound dehiscence, purulent wound, fever or signs of meningitis). Furthermore, CSF 
samples were taken for microbiological testing if a CSF leak occurred.  
All patients with an infection received broad-spectrum empiric antibiotic treatment after consulting a specialist for 
infectious diseases and amendments to the therapy plan were made if required by the results of the microbiological 
testing. Data on infectious complications were prospectively collected in our patient registry and completed with 
information from patient records of associated clinics, anesthesia protocols and intensive care unit records.  
Statistical Analysis 
Statistical analysis was performed with IBM® SPSS® Statistics, version 23 (IBM Corp., Armonk, NY, USA) and 
Microsoft® Excel® version 14.4.1 (Microsoft Corp, Redmond, WA, USA). Figures were created using Prism 7 
software (GraphPad Software Inc., San Diego, CA, USA). Univariate logistic regression was used to determine, 
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whether the number of infections was correlated to the cumulative number of operations performed in the new 
ioMRI setting. Significance was defined as p<0.05.  
 
Results 
Patient cohorts and operative statistics 
Patient characteristics are listed in Table 1. The average age of the craniotomy group is considerably lower than in 
the transsphenoidal group (40 (21, 57) vs. 46 (33, 63.75) years median age and quartiles) due to the high proportion 
of pediatric patients in this cohort (22%). The majority of the procedures were first-time operations (83% of the 
transsphenoidal procedures, 58% of the craniotomies). Craniotomies were performed for revascularization (10%) and 
resection of tumors (glioma in 72% of all craniotomies). The most frequent pathology requiring transsphenoidal 
surgery was pituitary adenoma (83%). The remaining pathologies included craniopharyngioma, mesenchymal tumors 
and meningioma. Median duration of the craniotomies reported in this study (including time for ioMRI and transfer) 
was 340 minutes with 94 (86%) procedures exceeding 4 hours. The median duration of transsphenoidal skull base 
surgeries reported in this study (including time for ioMRI and transfer) was 200 minutes with 25 (29%) operations 
exceeding the operating time of 4 hours. 
 
Surgical site infections 
Complications that occurred in both operative groups are listed in Tables 2 and 3. SSIs were observed in six 
craniotomies (5.5% 95%-Confidence interval [CI]: 1.2%, 9.8%), of which five (5%) classified as deep 
incisional/organ-space SSIs (Table 2). These include two cases of bone flap osteitis (2%), two cases of meningitis-
ventriculitis (2%) and one epidural abscess (1%). CSF fistula occurred in one case (1%). Infection-related wound 
revision surgery was necessary in four cases (4%). The revision surgery included bone flap removal and subsequent 
cranioplasty in three patients, whereas one patient had repeated superficial wound revisions, a VP-shunt placement 
and dural reconstruction. All patients with an SSI received antibiotic treatment. The most frequent cultures were 
Staphylococcus aureus (three cases, 50%) and Citrobacter koseri (two cases, 33%). Other identified pathogens 
included Acinetobacter and Pseudomonas aeruginosa (Table 4). Mean operative time of craniotomies that were 
followed by an SSI (including time for ioMRI and transfer) was 360 minutes and five of these procedures lasted 
longer than four hours (Table 4). No craniotomy patient with an SSI had recent neurosurgery within 30 days prior to 
the operation. 
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Six cases of SSI (7.0% 95%-CI: 1.5%, 12.4%) occurred in the transsphenoidal group (Table 3). Two patients (2%) 
had intranasal infections without direct connection to the CNS (one septum abscess and one bacterial rhinosinusitis) 
and four patients (5%) had meningitis coinciding a CSF leak. Overall, CSF leaks after transsphenoidal surgery was 
observed in nine cases (10%). Five patients (6%) with infections required revision surgery (four CSF leak closures 
and one intranasal abscess drainage). All patients with an infection received antibiotic treatment. Pathogens were 
identified in four patients, of which three (50%) had Staphylococcus aureus (Table 4). Other pathogens included 
Citrobacter freudii, Pseudomonas aeruginosa, Staphylococcus epidermidis and Finegoldia magna. Mean operative 
time of the transsphenoidal surgeries that were followed by an infection (including time for ioMRI and transfer) was 
243 minutes, while only one of these lasted longer than four hours (Table 4). No patient of this group with an 
infection had recent neurosurgery within 30 days prior to the operation. 
Considering all operations of both types, logistic regression showed that the likelihood of SSIs was significantly 
negatively associated with the accumulative number of operations performed in this new setting (odds ratio: 0.982; 
95%-CI: 0.969-0.995, p=0.008). 
 
Discussion 
Incidence of SSIs in neurosurgical operations with shared-resource ioMRI is within normal range 
In this study, we have evaluated the incidence of postoperative infections in neurosurgical procedures that involved a 
shared-resource ioMRI. 
During the study period, we performed 109 craniotomies and 86 transsphenoidal skull-base surgeries with 
involvement of a shared-resource ioMRI and observed six cases of SSI (5.5%) among craniotomy patients and six 
cases of postoperative infection among patients that underwent transsphenoidal surgery (7.0%), although only four of 
the infections in the transsphenoidal group affected the CNS (5%). All patients with meningitis after transsphenoidal 
skull base surgery had a CSF leak, received a lumbar drain and required endoscopic repair of the CSF leak. 
Furthermore, four craniotomy patients (4%) needed to have at least one unplanned reoperation for infection-related 
wound revision and three of these patients (3%) needed an extensive revision surgery with bone flap removal (Tables 
2 and 4). 
Previous studies without specific inclusion of intraoperative MRI reported SSI rates after craniotomy that vary 
between 1% and 8% with CNS infection rates after transsphenoidal surgery varying between 1.6% and 10%.19,22-35 A 
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study on complications in glioma surgery with use of a one-room ioMRI operating suite recently reported a 1.4% 
incidence of SSIs. Furthermore, others have reported rates of infection-related reoperations after craniotomy that 
vary between <1% and 4%.26, 27, 36 
Both operative groups in our study have an SSI rate that is within the upper half of the range mentioned above. Also, 
our infection-related reoperation rate after craniotomy is in the upper range of rates described in previous reports.  
Pathogens similar to infections without ioMRI 
The most frequent pathogen identified in this series of postoperative infections was Staphylococcus aureus (50% of 
the pathogens in both groups). Staphylococcus aureus is associated with the flora of the skin as well as the 
nasopharynx and has been previously identified as the most frequent bacterial pathogen in craniotomy and 
endoscopic skull base surgery.12,24,28,29,31,36 Gram-negative bacilli associated with nosocomial infections 
(Acinetobacter, Citerobacter, Pseudomonas aeruginosa) were found in 42% of the infections. This is above the 35% 
found in a study on meningitis after craniotomy and lower than the percentage of gram-negative bacilli observed in a 
study focusing on meningitis after endoscopic endonasal surgery.31,37  
Adaptation to new operative protocol and operative complexity contributed to infection rate 
It is possible that a selection bias contributed to the marginally higher infection and reoperation rates in the 
craniotomy group. The scanner was predominantly used in complex cases that are longer in duration and thus more 
prone to perioperative infections. In fact, 86% of all craniotomies (and five out of the six procedures that were 
followed by an SSI) lasted longer than four hours, which has been identified as a risk factor for infections in 
craniotomy patients.19  
Furthermore, it is noteworthy that almost all infections occurred in the first half of consecutive operations in this 
study (Figure 2). Among the 109 craniotomies, five infections occurred in the first 55 operations and one infection in 
the following 54 operations. Similarly among the transsphenoidal surgeries, all six infections occurred in the first 43 
operations and no infection occurred in the successive 43 operations (Table 4). This observation is supported by the 
result of the logistic regression analysis, which shows that the likelihood of infection significantly decreases with the 
cumulative number of operations performed in the new setting. Since the two-room ioMRI suite began operating at 
the same time as the study period, we attribute a part of these early infections to the novelty of the operative setting. 
The surgeons and the OR staff needed to adapt to a new operative protocol and new hygiene standards of the non-
sterile environment. The decreasing number of infections throughout the study period indicates that a learning curve 
effect has occurred and underlines the importance of extensive surgical staff training when such a new operative 
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setting is introduced. Although we observed relatively high overall infection and reoperation rates, it is encouraging 
that the infection rates throughout the study period decreased and we anticipate them to approach and remain at 
around 1-2%.  
Limitations 
This is a preliminary report and we will continue to prospectively collect further data. A limitation of this study is 
that the analysis was not adjusted for patient-related factors, such as age and preoperative chemotherapy or steroid 
use, that have been associated with increased SSI risk in neurosurgery.23, 29 Also, our results cannot be generalized to 
all centers since this is a single-center study. As such, the study is insufficiently powered to provide a conclusive 
answer for higher SSI risk in ioMRI settings. Adequately powered analysis would require a prospective multi-center 
collaboration. 
 
Conclusion 
Despite transportation into a non-sterile environment and prolonged operation time, the use of a two-room ioMRI in 
neurosurgical procedures did not demonstrate elevated infection rates compared to other studies. However, the 
incidence of postoperative infections in both study groups was initially higher than targeted. The likelihood of 
infection significantly decreased with the number of operations, underlining the importance of surgical staff training 
after the introduction of the novel operative setting. 
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Figure and table legends 
Figure 1.  Two-room ioMRI operating suite (A) Floor plan of the operating suite. The suite is separated in two 
distinct areas, the OR-compartment (blue) and the radiology-compartment (green) that is accessible for outpatient 
examinations. The ioMRI-room (red) is accessible from both compartments. 
(B) Transfer of the patient into the ioMRI. (Bi) A mobile MRI-table is pulled into the OR and docked to the OR-
table. (Bii) The patient is transferred onto the MRI-table via a floating table top. (Biii) The patient is directed into the 
scanner on the mobile MRI-table. 
Figure 2. Cumulative number of surgeries over time (grey) and number of SSIs at time of appearance (black). The 
considerably high infection incidence in the beginning and the subsequent decline demonstrate the learning curve 
effect that occurred in this new two room setting. 
 
Table 1. Patient Characteristics 
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Table 2. Complications after craniotomy with two-room ioMRI 
Table 3. Complications after transsphenoidal skull base surgery with two-room ioMRI 
Table 4. Characteristics of the 12 cases with infections after neurosurgical procedure with two-room ioMRI 
 
